Navigation Links
Halozyme Therapeutics Reports 2008 Third Quarter Financial Results
Date:11/6/2008

er cancer patients has been initiated that will test immediate post operative (IPOP) intravesical administration of Chemophase, the combination of rHuPH20 with mitomycin C immediately following transurethral resection of bladder tumor (TURBT). Results of this small safety study will be used to support the inclusion of the IPOP dosing regimen as part of the protocol in future Chemophase studies. Halozyme is making preparations to meet with regulatory authorities during the first half of 2009 to discuss the trial design for potential registration studies.

-- Halozyme hosted its first Research Day for financial analysts and the investment community on October 6, 2008 in New York. The well attended event provided a forum for an in depth presentation and discussion by the Halozyme management team of its proprietary product development pipeline, its plans for future clinical trials, and its business strategy. A replay of the meeting can be found on the Halozyme website. (http://phx.corporate-ir.net/phoenix.zhtml?c=175436&p=irol-calendar)

-- The company has recently strengthened its senior management team with the addition of Douglas B. Muchmore, M.D., Vice President, Endocrinology Clinical Development, Patrick O'Connor, Ph.D., Vice President, Research, Michael J. LaBarre, Ph.D., Vice President, Product Development, and James E. Cartoni, Vice President, Legal. Successfully recruiting, developing, and retaining high caliber, experienced executives exemplifies Halozyme's commitment to exceptional talent.

-- Positive pre-clinical animal efficacy data (http://www.halozyme.com/2008AACRTCsk-4%20-%20large.pdf)were presented for PEGPH20 at the American Association for Cancer Research (AACR) Translational Cancer Medicine meeting in Monterey, Calif. on July 21, 2008. The study demonstrat
'/>"/>

SOURCE Halozyme Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Halozyme Therapeutics Begins Phase 2 Clinical Trial of Insulin With rHuPH20 in Type 1 Diabetic Patients
2. Halozyme Therapeutics Announces Conference Call on November 6 to Review Third Quarter Results
3. Halozyme Therapeutics to Present at Upcoming Investor Conferences
4. Halozyme Therapeutics to Host Research Day for Investors and Analysts
5. Halozyme Therapeutics Appoints Head of Endocrinology Clinical Development
6. Halozyme Therapeutics to Present at Upcoming Investor Conferences
7. Halozyme Therapeutics Strengthens Management Team, Appoints Additional Experienced Executives
8. Halozyme Therapeutics Reports 2008 Second Quarter Financial Results
9. Halozyme Therapeutics to Present at the Jefferies 2nd Annual Healthcare Conference
10. Halozyme Therapeutics Reports 2008 First Quarter Financial Results
11. Halozyme Therapeutics to Hold Pipeline Update Conference Call on May 9
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... CA (PRWEB) August 28, 2014 ... is offering a promotion for Eppendorf Safe ... customers to purchase the highest quality tubes at ... are ideal for customers doing chemical, medical, pharmaceutical, ... technicians who are not regularly able to afford ...
(Date:8/27/2014)... Austin, TX (PRWEB) August 27, 2014 ... $6 million in Series B funding and secured Otter ... and investment capital will accelerate commercialization of GGI’s Agriplier™ ... multiple crop types. , “Since our first meeting, ... commitment to the biological product space,” said Alan Sobba, ...
(Date:8/27/2014)... , Aug. 27, 2014 Reportlinker.com ... is available in its catalogue: ... http://www.reportlinker.com/p02316661/Global-Biodegradable-Packaging-Materials-Market-2014-2018.html ... materials that are readily decomposed by the ... conventional non-degradable packaging in terms of raw ...
(Date:8/27/2014)... (PRWEB) August 27, 2014 The Global ... in-depth study on the current state of the Trifluoroacetic ... provides a basic overview of the industry, including definitions, ... Chinese domestic market analysis are provided with a focus ... market. A comparison between the international and Chinese situation ...
Breaking Biology Technology:Eppendorf Safe Lock Centrifuge Tube Promotion Now Available at Major Pipette Distributor Pipette.com 2Eppendorf Safe Lock Centrifuge Tube Promotion Now Available at Major Pipette Distributor Pipette.com 3Green & Grow Inc. Secures $6M Series B Funding from Otter Capital 2Green & Grow Inc. Secures $6M Series B Funding from Otter Capital 3Global Biodegradable Packaging Materials Market 2014-2018 2Global Biodegradable Packaging Materials Market 2014-2018 3Global Biodegradable Packaging Materials Market 2014-2018 4Global Biodegradable Packaging Materials Market 2014-2018 5Global Biodegradable Packaging Materials Market 2014-2018 6Global Biodegradable Packaging Materials Market 2014-2018 7Trifluoroacetic Acid Industry (Asia, Europe, North America, ROW) Analysis Report Now Available at ReportsnReports.com 2
... Ga., March 23 ArunA Biomedical, Inc., ... of Edina, MN, giving Neuromics the right to ... Neural Cells and Neural Culture Medium to support ... )ArunA has an exclusive worldwide license to develop ...
... veteran journalist Bill Scanlon has joined the company to ... addition to the staff marks a significant evolution in ... will aid in the introduction of the public to ... experience in science, medical and business writing to NanoLogix, ...
... Lends Experience To Antimicrobial Leader.SHREVEPORT, La., March 23 ... authorities in the poultry industry, has joined SteriFx ... expertise to SteriFx, a leader in developing non-toxic ... healthcare, defense and other industries. "We,re honored and ...
Cached Biology Technology:ArunA Biomedical, Inc. Announces Alliance with Neuromics for Distribution of Normal Human Neural Cells 2NanoLogix Adds Noted Journalist Bill Scanlon to Provide Media Relations 2Dan Blackshear Joins SteriFx Inc. 2
(Date:8/27/2014)... Most of North America,s megafauna mastodons, short-faced bears, ... horses disappeared close to 13,000 years ago at ... this massive extinction has long been debated by scientists ... , A group of scientists, including UC Santa Barbara,s ... Science, posited that a comet collision with Earth played ...
(Date:8/27/2014)... Orange, NJ. August 27, 2014. Using functional near ... differential brain activation patterns between people with multiple ... first MS study in which brain activation was ... task. The article, "Neuroimaging and cognition using functional ... published online on June 11 by Brain ...
(Date:8/27/2014)... Duke University researchers have identified a gene that could ... encodes a protein in the cell membrane of plants ... plant,s water conservation machinery accordingly. , "It,s similar ... of biology at Duke. , The findings, which ... could make it easier to feed the world,s growing ...
Breaking Biology News(10 mins):Nanodiamonds are forever 2Nanodiamonds are forever 3Kessler Foundation researchers publish first study of brain activation in MS using fNIRS 2Water 'thermostat' could help engineer drought-resistant crops 2
... normally reside on the skin of healthy people can ... researchers at the Swedish medical university Karolinska Institutet have ... of staphylococcus can attach itself to the skin and ... self-adhesive hairballs. Staphylococcus establishes itself on ...
... a seminar at another institution several years ago, ... hostile question: Why bother classifying organisms according to ... dynamics, when molecular techniques had already invalidated that ... in the audience nodding their agreement, Jablonski, the ...
... Israeli start-up company, launched its first "solar farm" near Tel ... developed by Prof. David Faiman of Ben-Gurion University of ... Faiman, who is chairman of the Department of Solar ... Desert Research, believes the new system will harvest more than ...
Cached Biology News:Tufted bacteria cause infection in premature babies 2Analysis finds strong match between molecular, fossil data in evolutionary studies 2Ben-Gurion University research and technology used in new solar energy farm 2